Marek Koprowski
Overview
Explore the profile of Marek Koprowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Owsianik K, Rozycka-Sokolowska E, Koprowski M, Turek M, Knopik L, Vivek V, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38339017
The reaction of (acetalaryl)arylmethanols with various phosphines PRRR (R = R = R = Ph; R = R = Ph, R = Me and R = R = Me, R...
2.
Turek M, Rozycka-Sokolowska E, Koprowski M, Marciniak B, Balczewski P
Molecules
. 2023 Sep;
28(18).
PMID: 37764366
The ecotoxicological impact of pharmaceuticals has received considerable attention, primarily focusing on active pharmaceutical ingredients (APIs) while largely neglecting the potential hazards posed by pharmaceutical excipients. Therefore, we analyzed the...
3.
Marciniak B, Kania S, Balczewski P, Rozycka-Sokolowska E, Wilk J, Koprowski M, et al.
Molecules
. 2023 Sep;
28(17).
PMID: 37687251
The functionalization of the aromatic backbone allows the improvement of the electrical properties of acene molecules in the amorphous layered structures of organic thin films. In the present work, we...
4.
Majewski S, Bialas A, Barczyk A, Batura-Gabryel H, Buchczyk M, Doboszynska A, et al.
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510750
Nintedanib is a disease-modifying agent licensed for the treatment of IPF. Data on Polish experience with nintedanib in IPF are lacking. The present study aimed to describe the safety and...
5.
Koprowski M, Owsianik K, Knopik L, Vivek V, Romaniuk A, Rozycka-Sokolowska E, et al.
Molecules
. 2022 Oct;
27(19).
PMID: 36235148
This comprehensive review, covering the years 1968-2022, is not only a retrospective investigation of a certain group of linearly fused aromatics, called acenes, but also a presentation of the current...
6.
Woloch S, Kurnik J, Szlubowski A, Gnass M, Koprowski M, Undas A
Pol Arch Intern Med
. 2021 Oct;
131(12).
PMID: 34698469
No abstract available.
7.
Balczewski P, Kowalska E, Rozycka-Sokolowska E, Uznanski P, Wilk J, Koprowski M, et al.
Materials (Basel)
. 2021 Jul;
14(13).
PMID: 34201740
While few studies show only symmetrical and poorly mono-SO (n = 0-2) substituted acenes, in this study, we present a synthesis of a new group of unsymmetrical, significantly substituted derivatives,...
8.
Jaszczak-Wilke E, Polkowska Z, Koprowski M, Owsianik K, Mitchell A, Balczewski P
Molecules
. 2021 Apr;
26(8).
PMID: 33924691
Amygdalin (d-Mandelonitrile 6--β-d-glucosido-β-d-glucoside) is a natural cyanogenic glycoside occurring in the seeds of some edible plants, such as bitter almonds and peaches. It is a medically interesting but controversial compound...
9.
Turek M, Rozycka-Sokolowska E, Koprowski M, Marciniak B, Balczewski P
Mol Pharm
. 2021 Apr;
18(5):1970-1984.
PMID: 33792313
Physicochemical properties, in particular solubility and the associated bioavailability, are key factors in determining efficacy of poorly water-soluble drugs, which constitute 40% of new drugs in the market, and improving...
10.
Skalik J, Koprowski M, Rozycka-Sokolowska E, Balczewski P
Materials (Basel)
. 2020 Oct;
13(21).
PMID: 33114241
The interest in functional materials possessing improved properties led to development of new methods of their synthesis, which allowed to obtain new molecular arrangements with carbon and heteroatom motifs. Two...